Home › NDC Lookup › RxCUI directory › RxCUI 1373493

Dimethyl fumarate 240 MG Delayed Release Oral Capsule [Tecfidera] — RxCUI 1373493

RxNorm drug concept · Semantic branded drug
RxCUI 1373493 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1373493
Official nameDimethyl fumarate 240 MG Delayed Release Oral Capsule [Tecfidera]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTecfidera 240 MG Delayed Release Oral Capsule
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,405 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dimethyl Fumarate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dimethyl fumarate (brand name Tecfidera, also available as a generic) is a prescription medicine for adults with relapsing forms of multiple sclerosis — meaning MS that comes and g...
  • What exactly is dimethyl fumarate used for?
  • The two most common things people notice early on are flushing — a sensation of warmth, redness, or tingling, usually in the face and chest — and stomach upset like belly pain, nau...
  • What side effects should I expect, especially when I first start?
📖 Read our full Dimethyl Fumarate guide →

🕸️ Concept Web — How Dimethyl fumarate 240 MG Delayed Release Oral Ca... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dimethyl fumarate 240 MG Delayed Release Oral Capsule [Tecfidera] RxCUI 1373493

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dimethyl fumarate 1373478
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tecfidera 1373484
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dimethyl fumarate Delayed Release Oral Capsule 1373482
    • Dimethyl fumarate Oral Product 1373480
    • Dimethyl fumarate Pill 1373481
    • Dimethyl fumarate Delayed Release Oral Capsule [Tecfidera] 1373486
    • Tecfidera Oral Product 1373487
    • Tecfidera Pill 1373488
    • Delayed Release Oral Capsule 316995
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1373493 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64406-0005-01 1 BOTTLE, PLASTIC in 1 CARTON (64406-005-01) / 14 CAPSULE i... TECFIDERA Biogen Inc. 2013-03-27
64406-0006-02 1 BOTTLE, PLASTIC in 1 CARTON (64406-006-02) / 60 CAPSULE i... TECFIDERA Biogen Inc. 2013-03-27
64406-0007-03 1 KIT in 1 KIT (64406-007-03) * 14 CAPSULE in 1 BOTTLE, PL... Tecfidera Biogen Inc. 2013-03-27
Observed labelers: Biogen Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.